Rituxan (rituximab)

pCPA File Number: 20962
Negotiation Status:
Negotiations were not pursued
Indication(s):
Acute Lymphoblastic Leukemia (ALL)
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0102-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: